![Mark Robbins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Mark Robbins worked as Vice President-Clinical & Regulatory Affairs at DiaMedica Therapeutics, Inc. from 2013 to 2015.
He was also President at Tansna Therapeutics, Inc. and Chief Scientific Officer & EVP Legal Operations at Upsher-Smith Laboratories LLC.
Former positions of Mark Robbins
| Companies | Position | End |
|---|---|---|
Tansna Therapeutics, Inc.
 Tansna Therapeutics, Inc. Medical DistributorsDistribution Services Develops and offers oral drugs to treat epilepsy | President | 2018-09-30 |
| DIAMEDICA THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2015-01-19 |
Upsher-Smith Laboratories LLC
 Upsher-Smith Laboratories LLC Pharmaceuticals: MajorHealth Technology Manufactures and markets generic pharmaceutical products | Chief Operating Officer | 2013-01-09 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
3
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
DiaMedica Therapeutics, Inc.
 DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Tansna Therapeutics, Inc.
Tansna Therapeutics, Inc. Medical DistributorsDistribution Services Develops and offers oral drugs to treat epilepsy | Distribution Services |
Upsher-Smith Laboratories LLC
Upsher-Smith Laboratories LLC Pharmaceuticals: MajorHealth Technology Manufactures and markets generic pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Mark Robbins
